Novartis trial shows no benefits from Pear's schizophrenia app as CEO cites trial irregularities

Jan 14, 2021 (Jonah Comstock), Mobile Health News
The results will not impact the current rollout of a new version of the app, under special FDA guidelines.

Read the full story...

Trending healthcare news keywords at this moment

covid- vaccine pandemic cancer covid vaccines study